FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
9.50
+0.01 (0.16%)
At close: Aug 15, 2025, 4:00 PM
9.44
-0.06 (-0.58%)
After-hours: Aug 15, 2025, 7:36 PM EDT
FibroGen Market Cap
FibroGen has a market cap or net worth of $38.40 million as of August 15, 2025. Its market cap has decreased by -28.50% in one year.
Market Cap
38.40M
Enterprise Value
108.16M
1-Year Change
-28.50%
Ranking
Category
Stock Price
$9.50
Market Cap Chart
Since November 14, 2014, FibroGen's market cap has decreased from $1.22B to $38.40M, a decrease of -96.87%. That is a compound annual growth rate of -27.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 38.40M | -28.09% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
| Nov 14, 2014 | 1.22B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 629.52B |
| Johnson & Johnson | 425.41B |
| AbbVie | 365.13B |
| UnitedHealth Group | 275.33B |
| AstraZeneca | 243.89B |
| Novartis AG | 239.15B |
| Abbott Laboratories | 229.31B |
| Novo Nordisk | 227.24B |